Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Preventing Catheter-related Bacteremia When Administering Injectable Medications in Premature Infants.

NCT: NCT02633124 · TERMINATED

NCT IDNCT02633124
StatusTERMINATED
Start Date2016-01
Completion2020-05

Brief Summary

This study evaluates the potential interest of a new multi-lumen infusion access device (Edelvaiss® Multiline NEO) in the prevention of catheter-related bacteremia when administering injectable drugs in premature infants. This device will be compared to the standard infusion set of each center.

Frequently Asked Questions

What is Preventing Catheter-related Bacteremia When Administering Injectable Medications in Premature Infants.?

Preventing Catheter-related Bacteremia When Administering Injectable Medications in Premature Infants. is a clinical trial registered under NCT02633124. Current status: TERMINATED.

What is the status of NCT02633124?

The current status of NCT02633124 (Preventing Catheter-related Bacteremia When Administering Injectable Medications in Premature Infants.) is: TERMINATED.

When did Preventing Catheter-related Bacteremia When Administering Injectable Medications in Premature Infants. start?

Preventing Catheter-related Bacteremia When Administering Injectable Medications in Premature Infants. started on 2016-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑